Qualatomics
Qualatomics
  • Home
  • About
  • Contact
  • More
    • Home
    • About
    • Contact
  • Home
  • About
  • Contact

The New Standard in Nuclear Medicine Manufacturing



 Qualatomics is a new manufacturer and supplier of finished dose PET radiopharmaceutical drug products. Our flagship facility, with a convenient centralized location in New Jersey, is targeted to open in 2027 and will be able to supply high-quality, high-volume, finished doses to patients at hospitals and clinics throughout the New York Metro area.



Learn more

Small Footprint - Wide Coverage

We're building a state-of-the-art manufacturing facility with access to some of the nation's most premier hospitals.

PET Manufacturing for the 21st Century

Our Mission

Our Capabilities

Our Mission

Qualatomics aims to deliver reliable, high-quality radiopharmaceuticals to accelerate patient care, starting with our Flagship Facility in the New York Metro area. Launching in 2027, this site will be a scalable model for a nationwide coverage network. Our mission is to increase the availability of a variety of tracers and isotopes to meet patients where they are.

Our Purpose

Our Capabilities

Our Mission

In an era of advancing precision medicine, timely access to PET isotopes is critical yet often constrained. Qualatomics aims to bridge this gap using cutting-edge manufacturing techniques and high-quality engineering to ensure supply chain resilience, regulatory excellence, and seamless integration of diagnostic and therapeutic manufacturing capabilities.

Our Capabilities

Our Capabilities

Our Capabilities

Our Flagship Facility, centrally located in New Jersey, will provide robust PET tracer and isotope manufacturing which can be supplied to many of the top hospitals and clinics in the New York Metro area. Our efficient, high-yield manufacturing processes and optimal location reduce logistic complexities and accelerate delivery to healthcare providers.

Our Isotopes

Our Manufacturing

Our Capabilities

Our cyclotron facility will support both liquid and solid targetry for an array of isotopes, including Fluorine-18 (F-18), Gallium-68 (Ga-68), Zirconium-89 (Zr-89), and Copper-64 (Cu-64), and more. With ample space for generator-based processes as well, we are confident in our ability to rise to whatever the ever-evolving landscape presents.

Our Manufacturing

Our Manufacturing

Our Manufacturing

Our flexible manufacturing lines will be fully equipped to support the implementation of virtually any radiotracer manufacturing process. From target extraction, through synthesis on multiple automated platforms, and dispensing into syringes or vials, our flexibility allows us to serve our patients in whatever way is best for them.

Our Experience

Our Manufacturing

Our Manufacturing

Our leadership team has extensive experience in manufacturing operations. By bringing on the best and brightest of industry talent, we can rapidly tackle manufacturing challenges, optimize yields and run times, and implement innovative solutions to stay on the forefront of manufacturing. 

Interested In Learning More or Joining our Team?

Partnership InquiriesCareersOur Team

Copyright © 2025 Qualatomics - All Rights Reserved.


This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept